TOP STORIES

• BUSINESS Takeda’s OTC Unit to Be Renamed Alinamin with New Chief from Blackstone
  March 22, 2021

• REGULATORY MHLW to Set Up Medical Supply Office in April after COVID-19, Antibiotic Shortage
  March 19, 2021

• ORGANIZATION Trade Groups Push Proper Pricing of Innovative Drugs to Restore Attractiveness of Japan: LDP Confab
  March 19, 2021

• ORGANIZATION With Aducanumab in Mind, Outgoing Chuikyo Payer Rep Floats Rule to Reward Cost Cuts for Pricey Meds
  March 18, 2021

• BUSINESS Morimoto Pharma Looking to Partner with Drug Makers, CMOs to Develop Freeze-Dried COVID Vaccines in Japan
  March 17, 2021

• BUSINESS Quake-Halted Nipro Plant Affecting Supplies of Pfizer, Espha Generics
  March 17, 2021

• BUSINESS Alesion Dry Syrup, Generics Pulled from Shelves over Mutagenic Impurities
  March 16, 2021

• BUSINESS Takeda Appoints Milano Furuta as New Japan Chief
  March 16, 2021

• ACADEMIA Tokushukai Weighs Switches from Nichi-Iko Products after Biz Suspension Order
  March 15, 2021

• BUSINESS Me Pharma Eyes Production of 1 Billion Tablets in FY2021, Sales Buoyed by Low Prices
  March 12, 2021

• BUSINESS JMA Affiliate Data Operator Poised to Provide RWD from NHO Hospitals to Drug Makers
  March 11, 2021

• BUSINESS Takeda to Buy Out T-Cell Engager Specialist Maverick for US$525 Million
  March 11, 2021

• BUSINESS 70% of Major Products Fall Victim to Off-Year Drug Re-Pricing: Jiho Tally
  March 10, 2021

• BUSINESS Top-Tier Drug Makers Face 2-4% Cuts, Mid-Sized Firms 6-8% in Japan’s First Off-Year Re-Pricing: Tally
  March 9, 2021

• BUSINESS Top-3 Generic Makers Hit with Average 9.8% Price Cut in Off-Year Revision: Jiho Tally
  March 9, 2021

• BUSINESS Takeda Aims for Mid-Teens Annual Growth in Japan Oncology Biz: Exec
  March 8, 2021

• REGULATORY MHLW Presents Views on “Pharma Industry Vision 2021” to LDP’s Project Team
  March 8, 2021

• REGULATORY Japan Confirms 1st Case of Anaphylaxis from COVID-19 Vaccination
  March 8, 2021

• REGULATORY Japan to Review Moderna Vaccine with Top Priority, May OK Possible: Minister
  March 8, 2021

• BUSINESS Takeda Submits NDA for Moderna Vaccine in Japan
  March 5, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 97
• 98
• 99
• 100
• 101
• 102
• 103
• 104
• 105
• …
• Next ›
• 最終 »